Disaggregation of Revenues, Geographic Sales and Product Sales

12 Months Ended

Jan. 01, 2021

Segment Reporting [Abstract]

Disaggregation of Revenues, Geographic Sales and Product Sales

Note 17 — Disaggregation of Revenues, Geographic Sales and Product Sales

In the following tables, revenues are disaggregated by category, sales by geographic market and sales by product data.  The following breaks down revenues into the following categories (in thousands):  

	Years Ended
	2020		2019		2018
Non-consignment sales	$	137,369	$	132,716	$	106,338
Consignment sales		26,091		17,469		17,616
Total net sales	$	163,460	$	150,185	$	123,954

The Company markets and sells its products in more than 75 countries and conducts its manufacturing in the United States. Other than China and Japan, the Company does not conduct business in any country in which its sales in that country exceed 10% of consolidated net sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers was as follows (in thousands):

	Years Ended
	2020		2019		2018
Domestic	$	6,158	$	8,106	$	7,316
Foreign:
China(1)		71,692		64,820		46,070
Japan		34,986		26,881		23,151
Other(2)		50,624		50,378		47,417
Total foreign sales		157,302		142,079		116,638
Total net sales	$	163,460	$	150,185	$	123,954

⁽¹⁾ The China region includes sales into China and Hong Kong.  

⁽²⁾ No other location individually exceeds 10% of the total net sales.

100% of the Company’s sales are generated from the ophthalmic surgical product segment and the chief operating decision maker makes the operating decisions and allocates resources based upon the consolidated operating results, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery.  The composition of the Company’s net sales by product line was as follows (in thousands):

	Years Ended
	2020		2019		2018
ICLs	$	141,407	$	129,322	$	101,082
Other product sales
IOLs		13,574		15,689		16,193
Other surgical products		8,479		5,174		6,679
Total other product sales		22,053		20,863		22,872
Total net sales	$	163,460	$	150,185	$	123,954

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, U.S. and foreign export and import duties and tariffs, and political instability